CXCL10-derived peptides do not only inhibit vessel formation and induce the involution of newly formed vessels [85]; these deformed and abnormal vessels may decrease the ingestion of chemotherapeutic drugs in tumour lesions too. Here, CXCL10 is linked to neoplasm.